IP / patents and trademarks


Intellectual property is an important part of Paradigm’s ownership of the repurposing programs that we run. We protect these programs through trade secrets, partnerships, patents and trade marks. We work closely with FB Rice in developing, registering and protecting our patents.


IP / trademarks


Intellectual property is an important part of Paradigm’s ownership of the repurposing programs that we run. We protect these programs through trade secrets, partnerships, patents and trade marks. We work closely with FB Rice in developing, registering and protecting our patents.

PATENTS & PATENT APPLICATIONS

Paradigm is pursuing 3 patent families in the areas of bone marrow edema (BME), respiratory disease : including allergic rhinitis, asthma and chronic obstructive pulmonary disease (COPD), and exosome technology.

1. Treatment of bone marrow edema (oedema) with polysulfated polysaccharides

Official No.TitleCase StatusCountry
2012212398Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesRegisteredAustralia
2,826,166Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesApplication pendingCanada
12741560.2Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesApplication pending Europe
6541/CHENP/2013Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesApplication pendingIndia
W-00201304009Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesApplication pending Indonesia
2013-552065Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesApplication allowed, patent grant expected April 2016Japan
PI2013701355Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesApplication pendingMalaysia
201280007433.9Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesApplication pending People's Republic of China
2013-7022985Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesApplication pendingRepublic of Korea
192238Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesRegisteredSingapore
101103252Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesApplication allowed, patent grant expected April 2016Taiwan
1301004283Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesApplication pendingThailand
14/790,476Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesApplication pendingUnited States of America
9,101,650Treatment of bone marrow edema (oedema) with polysulfated polysaccharidesRegisteredUnited States of America

2. Sulphated xylans for treatment or prophylaxis of respiratory diseases

Official No.TitleCase StatusCountry
2014200346Sulphated xylans for treatment or prophylaxis of respiratory diseasesApplication pendingAustralia
2008255565Sulphated xylans for treatment or prophylaxis of respiratory diseasesRegisteredAustralia
2689027Sulphated xylans for treatment or prophylaxis of respiratory diseasesApplication pendingCanada
08748030.7Sulphated xylans for treatment or prophylaxis of respiratory diseasesApplication allowed grant expected May 2016Europe
581544Sulphated xylans for treatment or prophylaxis of respiratory diseasesRegisteredNew Zealand
599928Sulphated xylans for treatment or prophylaxis of respiratory diseasesRegisteredNew Zealand
601148Sulphated xylans for treatment or prophylaxis of respiratory diseasesRegisteredNew Zealand
101686996Sulphated xylans for treatment or prophylaxis of respiratory diseasesRegisteredPeople's Republic of China
12/602,384Sulfated xylans for treatment or prophylaxis of respiratory diseasesApplication pendingUnited States of America
14/716,302Sulphated xylans for treatment or prophylaxis of respiratory diseasesApplication pendingUnited States of America

3. A method of producing exosomes

Patent Cooperation Treaty, Official number WO 2015/048844, Application pending

TRADEMARKS

Paradigm has Trademarked its proprietary formulations of Pentosan Polysulphate Sodium for treatment of bone marrow edema (Zilosul®) and Allergic Rhinitis (Rhinosul®).

ZILOSUL Trade Mark Portfolio March 2016

CountryRegistration #Trade MarkDescription CombinedStatus
AUSTRALIA1639602ZILOSUL5 - Pharmaceutical preparationsREGISTERED
HONG KONG303294180ZILOSUL5 - Pharmaceutical preparationsREGISTERED
WIPO1238470ZILOSUL5 - Pharmaceutical preparationsREGISTERED
CHINA1238470ZILOSUL5 - Pharmaceutical preparationsREGISTERED
EUROPEAN UNION (CTM)1238470ZILOSUL5 - Pharmaceutical preparationsREGISTERED
JAPAN1238470ZILOSUL5 - Pharmaceutical preparationsREGISTERED
NEW ZEALAND1015728ZILOSUL5 - Pharmaceutical preparationsREGISTERED
PHILIPPINES1238470ZILOSUL5 - Pharmaceutical preparationsREGISTERED
SINGAPORE1238470ZILOSUL5 - Pharmaceutical preparationsREGISTERED
TAIWAN1722127ZILOSUL5 - Pharmaceutical preparationsREGISTERED
CANADAZILOSUL5 - Pharmaceutical preparationsPENDING
INDIAZILOSUL5 - Pharmaceutical preparationsPENDING
UNITED STATESZILOSUL005 - Pharmaceutical preparations for the treatment of orthopedic conditionsPUBLISHED
VIETNAMZILOSUL5 - Pharmaceutical preparationsPENDING
INDONESIAZILOSUL5 - Pharmaceutical preparationsPENDING

# All Trademarks owned by Paradigm Biopharmaceuticals Ltd